Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 180, AC Immune, Acelrx, Agomab, Alligator, Aptevo, Asher, Astrazeneca, Atea, Benevolentai, Bionaut, Biontech, Bridgene, Candel, Glaxosmithkline, Humacyte, Iacta, Megapharm, Moderna, Nference, Ocugen, Orpharm, Pfizer, Quoin, Som, Tallc, Transgene, Vir.